YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Australian treasurer Jim Chalmers is flagging budget cuts as global turmoil bites, yet still expects the country to avoid recession. That mix of pressure and resilience often leaves high quality companies mispriced when investors crowd int…
Boots is nearing a roughly £7 billion sale deal to the Canadian branch of the billionaire Weston family, according to reports. Private equity owner Sycamore is in advanced talks over the sale, only a year after taking over Boots through th…
Foreign investors have poured a record US$942b into US equities over 12 months, which leaves plenty of global money hunting for the next pocket of value. That spotlight often shifts to Australian businesses with strong cash generation and…
This article first appeared on GuruFocus. Revenue: Group revenue grew 15.5% to $10.8 billion. Normalized EBIT: Increased over 20% to almost $1.1 billion, with EBIT margin expanding 43 basis points to 10.1%. Net Profit After Tax (NPAT): Sta…
This article first appeared on GuruFocus. Sigma Healthcare (SIGGF) has pulled out of the Boots sale process, stepping away from a potential acquisition of the British pharmacy chain that could have been worth as much as $10 billion. The Au…
Sigma’s decision to pull out of talks places further uncertainty on Boots’s future - Mike Kemp The Australian pharmacy group Sigma Healthcare has dropped out of talks for a potential takeover of Boots, a deal that would have valued the Bri…
Australian pharmacy business Sigma Healthcare has pulled out of takeover talks to buy Boots. The UK beauty and pharmacy giant revealed last week that it had held early discussions over a potential takeover deal. However, on Monday, bosses…
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. If you are wondering whether Sigma Healthcare at A$2.69 is offering fair value or an appealing entry point, a good starting…
This article first appeared on GuruFocus. Sycamore Partners may be preparing for a much faster exit from Boots than investors previously expected. The private equity firm, which took control of Boots through its acquisition of Walgreens Bo…
Pharmacy and beauty chain Boots is in talks with an Australian rival and the billionaire Weston family over a potential £7.5 billion sale. Australian pharmacy group Sigma Healthcare confirmed on Wednesday that it has held “preliminary disc…
A takeover of Boots would derail plans for a stock market listing - Mike Kemp/Getty Images Boots is in talks to sell itself for £7.5bn to the family behind Primark and an Australian pharmacy chain. The billionaire Weston family, which owns…
As the Australian market navigates a cautious start to the week, with modest gains and an eye on economic indicators and international developments, investors are closely monitoring potential opportunities. Penny stocks, despite their some…
The Australian share market is experiencing a challenging period, with a recent downturn marking its seventh consecutive day of declines. Amidst these broader market movements, penny stocks remain an intriguing option for investors interes…
This article first appeared on GuruFocus. Revenue Growth: Increased by 15% for the half-year. Chemists Warehouse Sales: Up 17% in the Australian network; like-for-like sales up 15%. International Sales Growth: Network sales up 24.5%; like-…
There are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two trends; firstly a growing return on capital employed (ROCE) and secondly, an increasing amount of capital employed. If y…
Key Insights Insiders appear to have a vested interest in Sigma Healthcare's growth, as seen by their sizeable ownership A total of 5 investors have a majority stake in the company with 52% ownership Analyst forecasts along with ownership…
Key Insights The projected fair value for Sigma Healthcare is AU$3.62 based on 2 Stage Free Cash Flow to Equity Sigma Healthcare's AU$3.12 share price indicates it is trading at similar levels as its fair value estimate The AU$3.23 analyst…
Most readers would already know that Sigma Healthcare's (ASX:SIG) stock increased by 5.6% over the past three months. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this instance. Particu…
It's been a good week for Sigma Healthcare Limited (ASX:SIG) shareholders, because the company has just released its latest yearly results, and the shares gained 9.5% to AU$3.12. Sigma Healthcare reported AU$6.0b in revenue, roughly in lin…
Key Insights Significant insider control over Sigma Healthcare implies vested interests in company growth A total of 4 investors have a majority stake in the company with 51% ownership Recent sales by insiders AI is about to change healthc…
Sigma Healthcare (ASX:SIG) Full Year 2025 Results Key Financial Results Revenue: AU$4.84b (up 46% from FY 2024). Net loss: AU$13.8m (down by 407% from AU$4.51m profit in FY 2024). AU$0.009 loss per share (down from AU$0.004 profit in FY 20…
In the wake of recent market volatility driven by global tariff tensions, Australian shares are poised for a significant downturn, with ASX 200 futures indicating a sharp decline. Amidst this challenging environment, identifying undervalue…
The Australian market has been experiencing some turbulence, with tariff uncertainties impacting investor sentiment and resulting in a mixed performance across sectors. Amidst this volatility, identifying undervalued stocks can be an attra…
(Reuters) - Proxy advisory firm Ownership Matters said on Monday it recommends that shareholders of Sigma Healthcare vote in favour of Chemist Warehouse's reverse takeover of the pharmaceutical company, citing significant shareholder value…
Jefferies downgraded Sigma Healthcare (SIGGF) to Underperform from Hold with a price target of A$1.85, up from A$1.60. Sigma advised that it expects the proposed merger with Chemist Warehouse implementation to occur in February, notes the…
By Sameer Manekar and Rishav Chatterjee (Reuters) - The Australian competition regulator, on Thursday, cleared privately owned pharmacy chain Chemist Warehouse's reverse takeover of Sigma Healthcare, paving the way to create an A$8.8 billi…
By Himanshi Akhand and Roushni Nair (Reuters) -Shares of Sigma Healthcare shot to their highest levels in 18 years on Tuesday, after the Australian healthcare group offered three major concessions to facilitate its A$8.8 billion ($6.09 bil…
Revenue: $1.8 billion, up 9.4% from the prior period. Normalized Revenue Growth: Up 17.3% after removing nonrecurring revenue. Gross Profit: Increased by $9.7 million or 8.8%. Normalized EBIT: $18 million, up 20%. Normalized NPAT: $13.7 mi…
Over the last 7 days, the Australian market has risen 2.1%, driven by gains in every sector, and has climbed 13% over the past year. In light of these strong performances and expected annual earnings growth of 12%, identifying stocks with…